Prestige Consumer Healthcare (FRA:PBV) 3-Year Revenue Growth Rate : 6.30% (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Prestige Consumer Healthcare 3-Year Revenue Growth Rate?

Prestige Consumer Healthcare's Revenue per Share for the three months ended in Dec. 2023 was €5.17.

During the past 12 months, Prestige Consumer Healthcare's average Revenue per Share Growth Rate was 3.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was 6.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was 3.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was 6.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Prestige Consumer Healthcare was 116.50% per year. The lowest was -14.60% per year. And the median was 10.35% per year.

Competitive Comparison of Prestige Consumer Healthcare's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Prestige Consumer Healthcare's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Prestige Consumer Healthcare's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Prestige Consumer Healthcare's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Prestige Consumer Healthcare's 3-Year Revenue Growth Rate falls into.

Prestige Consumer Healthcare 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Prestige Consumer Healthcare (FRA:PBV) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Prestige Consumer Healthcare 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Prestige Consumer Healthcare's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Prestige Consumer Healthcare (FRA:PBV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Prestige Consumer Healthcare Inc (FRA:PBV) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

PBH:USA

Address

660 White Plains Road, Tarrytown, NY, USA, 10591

Website

https://www.prestigebrands.com

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Prestige Consumer Healthcare (FRA:PBV) Headlines

No Headlines